De la maladie de Pick aux démences fronto-temporales = From Pick's disease to frontotemporal dementiaPASQUIER, Florence; DERAMECOURT, Vincent; LEBERT, Florence et al.Bulletin de l'Académie nationale de médecine. 2012, Vol 196, Num 2, pp 431-443, issn 0001-4079, 13 p.Conference Paper

Troubles cognitifs et insuffisance rénale: quels liens ? = Cognitive impairment and chronic kidney disease: Which links?GAXATTE, Cédric; DAROUX, Maïté; BLOCH, Jennifer et al.Néphrologie & thérapeutique. 2011, Vol 7, Num 1, pp 10-17, issn 1769-7255, 8 p.Article

What are the causes of pre-existing dementia in patients with intracerebral haemorrhages?CORDONNIER, Charlotte; LEYS, Didier; DUMONT, Frédéric et al.Brain. 2010, Vol 133, pp 3281-3289, issn 0006-8950, 9 p., 11Article

Prevalence of small cerebral bleeds in patients with a neurodegenerative dementia: A neuropathological studyDE REUCK, Jacques; DERAMECOURT, Vincent; CORDONNIER, Charlotte et al.Journal of the neurological sciences. 2011, Vol 300, Num 1-2, pp 63-66, issn 0022-510X, 4 p.Article

Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brainsFEUILLETTE, Sébastien; DERAMECOURT, Vincent; LECOURTOIS, Magalie et al.Brain research. 2010, Vol 1345, pp 182-189, issn 0006-8993, 8 p.Article

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementiaRASCOVSKY, Katya; HODGES, John R; HILLIS, Argye E et al.Brain. 2011, Vol 134, pp 2456-2477, issn 0006-8950, 22 p., 9Article

Comment les acteurs moléculaires de la pathologie Alzheimer permettent de comprendre la démence ? Quelles conséquences diagnostiques et thérapeutiques ? = Molecular Actors in Alzheimer's Disease: Which Diagnostic and Therapeutic Consequences?BUEE, Luc; BLUM, David; HUMEZ, Sandrine et al.Thérapie (Paris). 2010, Vol 65, Num 5, pp 401-407, issn 0040-5957, 7 p.Article

METHIONINE SYNTHASE DEFICIENCY: A RARE CAUSE OF ADULT-ONSET LEUKOENCEPHALOPATHYOUTTERYCK, Olivier; DE SEZE, Jérôme; ZEPHIR, Hélène et al.Neurology. 2012, Vol 79, Num 4, pp 386-388, issn 0028-3878, 3 p.Article

Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family membersFINCH, Nicole; BAKER, Matt; DICKSON, Dennis W et al.Brain. 2009, Vol 132, pp 583-591, issn 0006-8950, 9 p., 3Article

Absence of β-amyloid deposits after immunization in Alzheimer disease with lewy body dementiaBOMBOIS, Stéphanie; MAURAGE, Claude-Alain; GOMPEL, Marie et al.Archives of neurology (Chicago). 2007, Vol 64, Num 4, pp 583-587, issn 0003-9942, 5 p.Article

Microbleeds in Postmortem Brains of Patients With Alzheimer Disease: A T₂^*-weighted Gradient-Echo 7.0 T Magnetic Resonance Imaging StudyDE REUCK, Jacques L; CORDONNIER, Charlotte; DERAMECOURT, Vincent et al.Alzheimer disease and associated disorders. 2013, Vol 27, Num 2, pp 162-167, issn 0893-0341, 6 p.Article

Hippocampal Neuronal Atrophy and Cognitive Function in Delayed Poststroke and Aging-Related DementiasGEMMELL, Elizabeth; BOSOMWORTH, Helen; ALLAN, Louise et al.Stroke (1970). 2012, Vol 43, Num 3, pp 808-814, issn 0039-2499, 7 p.Article

CHMP2B mutations are rare in French families with frontotemporal lobar degenerationGHANIM, Mustapha; GUILLOT-NOEL, Léna; PASQUIER, Florence et al.Journal of neurology. 2010, Vol 257, Num 12, pp 2032-2036, issn 0340-5354, 5 p.Article

Phenotype variability in progranulin mutation carriers : a clinical, neuropsychological, imaging and genetic studyLE BER, Isabelle; CAMUZAT, Agnès; PUEL, Michèle et al.Brain. 2008, Vol 131, pp 732-746, issn 0006-8950, 15 p., 3Article